Envista Holdings Corporation (NYSE:NVST) Receives $22.33 Consensus Target Price from Analysts

Shares of Envista Holdings Corporation (NYSE:NVST) have earned an average rating of “Hold” from the fourteen analysts that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $22.75.

NVST has been the subject of several recent research reports. UBS Group increased their price objective on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday. Robert W. Baird set a $27.00 price target on Envista in a report on Friday, October 31st. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 26th. Stifel Nicolaus raised their price objective on shares of Envista from $25.00 to $27.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Mizuho set a $24.00 target price on shares of Envista and gave the company a “neutral” rating in a research note on Tuesday, January 20th.

Key Envista News

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q4 earnings beat and solid quarter — Envista reported $0.38 EPS vs. $0.32 consensus and showed revenue/operating progress for the quarter, prompting the market uplift. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Management issued stronger FY‑2026 guidance — Envista raised its EPS outlook to $1.350–$1.450, above Street expectations, which materially improves forward earnings visibility and is a key reason investors are buying the stock. Envista Holdings soars after beating Q4 estimates, issues strong guidance
• Positive Sentiment: Analyst lift — Stifel raised its price target to $27 with a Buy rating, adding upward pressure by signaling upside to the current stock level. Envista price target raised by Stifel
• Neutral Sentiment: Coverage & screeners highlight value traits — Zacks flagged Envista as a top-ranked value stock, which may attract value-oriented buyers but doesn’t directly change fundamentals. Envista is a Top-Ranked Value Stock
• Negative Sentiment: Valuation and margin context — despite the beat, Envista trades at a high reported PE (~275x trailing) and showed a thin net margin (~0.6%), leaving the name exposed if growth slips or if investors re-rate multiples; this is a risk to monitor even as near‑term sentiment is positive.

Envista Stock Performance

NVST stock opened at $24.81 on Tuesday. The firm has a 50 day simple moving average of $22.63 and a 200 day simple moving average of $21.16. Envista has a 52 week low of $14.22 and a 52 week high of $25.41. The stock has a market cap of $4.08 billion, a P/E ratio of 275.66, a P/E/G ratio of 1.05 and a beta of 1.01. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37.

Envista (NYSE:NVST) last released its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. The company had revenue of $750.60 million during the quarter, compared to the consensus estimate of $680.26 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The company’s revenue was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts anticipate that Envista will post 1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Envista

Several hedge funds have recently bought and sold shares of NVST. Holocene Advisors LP bought a new stake in shares of Envista during the 2nd quarter worth about $43,936,000. Norges Bank acquired a new stake in Envista in the 2nd quarter worth approximately $40,229,000. Alliancebernstein L.P. boosted its position in Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares during the period. Franklin Resources Inc. grew its holdings in Envista by 16.7% during the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock valued at $175,011,000 after purchasing an additional 1,284,767 shares during the last quarter. Finally, Balyasny Asset Management L.P. acquired a new position in Envista during the third quarter valued at approximately $24,260,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.